ZTS: Summary for Zoetis Inc. Class A Common Stoc - Yahoo Finance

UK Markets open in 4 hrs 17 mins

Zoetis Inc. (ZTS)


NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
54.99+0.80 (+1.48%)
At close: 4:02PM EDT

54.99 0.00 (0.00%)
After hours: 4:19PM EDT

People also watch
MNKZBHPRGOIDXXXYL
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous close54.19
Open54.68
Bid0.00 x
Ask0.00 x
Day's range54.59 - 55.15
52-week range45.28 - 56.50
Volume2,770,642
Avg. volume3,390,343
Market cap27.03B
Beta1.22
PE ratio (TTM)33.33
EPS (TTM)N/A
Earnings dateN/A
Dividend & yield0.42 (0.79%)
Ex-dividend dateN/A
1y target estN/A
Trade prices are not sourced from all markets
  • Capital Cube3 days ago

    Zoetis, Inc. – Value Analysis (NYSE:ZTS) : April 21, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Zoetis, Inc. a score of 81. Our analysis is based on comparing Zoetis, Inc. with the following peers – Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Parnell Pharmaceuticals Holdings Ltd., Aratana Therapeutics, Inc., Heska Corporation, ImmuCell Corporation, Sanofi Sponsored ADR, Phibro Animal Health Corporation ... Read more (Read more...)

  • Zoetis, Inc. breached its 50 day moving average in a Bullish Manner : ZTS-US : April 20, 2017
    Capital Cube5 days ago

    Zoetis, Inc. breached its 50 day moving average in a Bullish Manner : ZTS-US : April 20, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Zoetis, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Zoetis (ZTS) Inks Agreement to Acquire Nexvet Biopharma
    Zacks8 days ago

    Zoetis (ZTS) Inks Agreement to Acquire Nexvet Biopharma

    Zoetis Inc. (ZTS) announced an agreement to buy Nexvet Biopharma plc (NVET) for an aggregate equity valuation of approximately $85 million